Search

Author/Creator Riddell, A.

1. 2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948). (September 2015)

Authors:
Cunningham, D.; Smyth, E.; Stenning, S.; Stevenson, L.; Robb, C.; Allum, W.; Grabsch, H.; Alderson, D.; Riddell, A.; Chua, S.; Crosby, T.; Mason, R.; Griffin, M.; Mansoor, W.; Coxon, F.; Falk, S.; Rowley, S.; Sumpter, K.; Blazeby, J.; Langley, R.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S400
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HALT: targeted therapy with or without dose-intensified radiotherapy in oligo-progressive disease in oncogene addicted lung tumours. (January 2020)

Authors:
McDonald, F.; Guckenberger, M.; Popat, S.; Faivre-Finn, C.; Andratschke, N.; Riddell, A.; Hanna, G.; Franks, K.; Harrow, S.; Miles, E.; Patel, R.; Diez, P.; Kilburn, L.; Toms, C.; Bliss, J.
Journal:
Lung cancer
Issue:
Volume 139(2020)Supplement 1
Page Start:
S92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain. (1st December 2017)

Authors:
van den Besselaar, A. M. H. P.; Chantarangkul, V.; Angeloni, F.; Binder, N. B.; Byrne, M.; Dauer, R.; Gudmundsdottir, B. R.; Jespersen, J.; Kitchen, S.; Legnani, C.; Lindahl, T. L.; Manning, R. A.; Martinuzzo, M.; Panes, O.; Pengo, V.; Riddell, A.; Subramanian, S.; Szederjesi, A.; Tantanate, C.; ...
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 16:Number 1(2018)
Page Start:
142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗